Jardiance 25 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26F21QC
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,857
Award facts
- Contract value 100% obligated
- $10,856.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
On January 30, 2026, the Defense Logistics Agency awarded a delivery order valued at $10,856.60 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages). This competitively awarded, firm fixed-price contract carries an ultimate completion date of February 2, 2026, with performance to be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. The award involves no set-aside designation, indicating open competition among qualified vendors. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at up to $999,999,999.00 through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (which operates under the Amerisourcebergen brand), is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company maintains significant contract vehicles with multiple federal agencies and demonstrates substantial capability in fulfilling diverse pharmaceutical supply requirements across therapeutic domains including diabetes management, specialty medications, vaccines, and medical devices. The DLA, which funds this award through its medical supply chain operations, regularly leverages AmerisourceBergen's extensive distribution network to meet the pharmaceutical needs of military treatment facilities and veteran healthcare programs.
Quick answers
Who was awarded contract SPE2DR26F21QC?
SPE2DR26F21QC was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F21QC worth?
The government has obligated $10,857 on SPE2DR26F21QC.
Is contract SPE2DR26F21QC an order under another contract?
Yes. SPE2DR26F21QC is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F21QC competed?
The extent of competition for SPE2DR26F21QC was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award